Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

• by Allison DeAngelis, Elaine Chen, Adam Feuerstein

• May 7, 2026

The role of metabolic reprogramming in oocyte development: research progress and prospects

• by Yawen Li, Yu Liu, Jing Jin

• May 21, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

• by Weisong Zhang, Guangchen Liu, Xue Qu, Delong Cong, Yangyang Liu

• May 22, 2026